biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Aug 11, 2017 5:33pm

167 Views

Post# 26573033

RE:RE:RE:RE:RE:Trastuzumab distribution

Oui at least eye, thank you both, much appreciate these decimal points ajustements. Was a bit nervous this morning reading Bear downs finds. I for sure can't help readers like most posters here except digi. But then, even he helps to tell us when to buy and to sell if you have an ironic side. Luckily I can help you to end the weekend, we have Blues listening and school Sunday nights.
Iheart radio app, then scroll down to 97.7 chom fm, Sunday night 8:00pm to 10:00pm and join us alleycats on the black cat alley Facebook page.
that was my shameless plug for today, you can thank me after the chaud

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale